Navigation Links
Sorrento Therapeutics Receives Frost & Sullivan's Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
Date:6/6/2013

market potential, such as

PD-L1, PD-1, as well as G protein-coupled receptor (GPCR) antibodies for immunotherapy in oncology. It is also improving upon already approved therapies through its proprietary AfDC process. This enables Sorrento to capitalize on the familiarity and success of predecessors, such as Herceptin® or Erbitux®, while competitors are developing therapies from scratch, thus creating greater difficulty in establishing familiarity.

Overall, Sorrento's strength of IP, expert management team, funding history, market growth and positioning, expansion strategy, and product differentiation capabilities make it a worthy recipient of the 2013 Frost & Sullivan Global Investment Opportunity Award.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. is a publicly-traded, development-stage biopharmaceutical company focused on the acquisition, discovery, development and commercialization of novel and proprietary therapeutics for the treatment of a variety of disease conditions, including cancer, inflammation, and infectious diseases. Sorrento's objective is to develop and commercialize its late-stage, oncolytic drug candidate – Cynviloq™ – for multiple cancer indications, to identify drug development candidates derived from its proprietary human antibody libraries and, either independently or through partnerships, advance selected targets into preclinical or clinical development. Sorrento intends
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
6. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 Baebies, Inc. today announced the completion ... The oversubscribed round of financing included key investors Rex ... Cunning Capital, Triad, LLC, the Duke Angel Network and ... of Advanced Liquid Logic,s (ALL) former investors including Charleston ... "Rex is pleased to support this promising ...
(Date:7/28/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, announced ... after the market closes on Tuesday, August 4, 2015. ... the same day at 4:30 p.m. ET (1:30 p.m. ... corporate update. The live call may be ...
(Date:7/28/2015)... Oncology, Inc. (OTC: CSBR), engaged in the development of ... and use of oncology drugs, today announced its financial ... Fourth Quarter and Recent Business Highlights: , ... period result , Procured a quarterly record high ... Champions Oncology CEO, stated, "The end of fiscal 2015 ...
Breaking Medicine Technology:Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11
... MISSISSAUGA, Ontario, Aug. 23, 2011 Valeant Pharmaceuticals International, ... has filed a Notice of Intention to make a ... (the "TSX") and that the TSX has accepted the ... have the right to purchase for cancellation, commencing August ...
... BOSTON, Aug. 23, 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) ... will result in the reduction of more than $620,000 in ... settlement agreement and new consulting agreement will result in a ... Solos Endoscopy posted its financial statements for period ended June ...
Cached Medicine Technology:Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 2Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid 3Solos Endoscopy to Reduce Debt by Over $620,000 2
(Date:7/28/2015)... ... 2015 , ... Egg freezing is becoming an increasingly popular option ... As Dr. Michael Kettel explained in an article from the San ... for previous generations who had to make choices between their fertility and their career ...
(Date:7/28/2015)... San Antonio, TX (PRWEB) , ... July 28, 2015 , ... ... in Texas, is now offering the duodenal switch weight loss surgery procedure. ... weight management and bariatric surgery procedures, BMI of Texas is one of ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Bipolar disorder is ... a day to a few times a year. The World Health Organization (WHO) has ... the National Institute of Mental Health reveals that the United States has the highest ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... biologic-device combination products for the treatment of bone disorders and conditions of hair ... 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The issued patent ...
(Date:7/28/2015)... York, NY (PRWEB) , ... July 28, 2015 ... ... benefit management services to include a proprietary, web based clinical knowledge system, called ... that are evidence based. It provides physicians who are anticipating making a ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 2Health News:BMI of Texas Now Offering Duodenal Switch Surgery – Weight Loss Procedure Helps Obese Patients Lose Weight Quickly 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2
... Variations in Therapy Regimens, with Monotherapy Most Common in Elderly ... , ORLANDO, Fla., June 1 There are striking differences ... based on both age and geography, according to a new ... as a poster on Saturday at the 2009 ASCO (American ...
... ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including Montana, to oppose health care reform. ... Foundation, which has a record as a right-wing political operation ...
... , Group led by conservative political operative with ties to ... Public Campaign Action Fund issued a new investigative report ... the group behind the political ads running in eight states, ... funded by the Americans for Prosperity Foundation, which has a ...
... with ties to convicted lobbyist Jack Abramoff , , ... new investigative report today called "Viewers Beware of Anti-Health Care ... in eight states, including South Dakota, to oppose health care ... Foundation, which has a record as a right-wing political operation ...
... some also suffer PTSD years after treatment , MONDAY, ... aren,t following recommended guidelines on screenings for second cancers ... from post-traumatic stress disorder years after beating their disease, ... can be costly because childhood cancer survivors are more ...
... the Link between Healthy Living and Reducing Health Risks , ... -- Ten year olds aren,t typically at risk ... lead to stroke risk factors. A program run by Sacred ... a healthy lifestyle. In conjunction with parents and the ...
Cached Medicine News:Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 2Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 3Health News:'Viewers Beware' Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Montana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in Indiana 2Health News:"Viewers Beware" Report by Watchdog Group Exposes Conservative Group Behind Anti-Healthcare Ads Running in South Dakota 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 2Health News:Many Childhood Cancer Survivors Not Checking for Second Malignancies 3Health News:Sacred Heart Hospital Starts to Expose Students to Stroke Awareness at an Early Age 2